首页> 外文期刊>Reviews in Health Care >The management of critical bleeding in obstetrics
【24h】

The management of critical bleeding in obstetrics

机译:产科重症出血的处理

获取原文
           

摘要

Post-partum hemorrhage (PPH) is one of the most frequent causes of maternal death: worldwide it contributes for a 25% of deaths. The risk of death from pregnancy complications has decreased dramatically over the last few decades, but several evidences show they have not yet been reduced to a minimum. There is therefore the need for a further improvement in the quality of medical care. Purpose of this paper is to briefly outline an overview of the definition of PPH, with an illustration of the possible causes and treatments currently available. WHO defined PPH as excessive bleeding > 500 ml after vaginal delivery and severe PPH as bleeding in excess of 1,000 ml after vaginal delivery, but a variety of definitions for PPH have been proposed, yet no single satisfactory definition exists. Another crucial item regards the estimation of blood loss, too often based on a visual assessment and, therefore, inaccurate and minimized. However, in medical literature there are no specific classifications for severe bleeding in obstetrics. During pregnancy there are several changes in coagulation state: because haemostatic reference intervals are generally based on samples from non-pregnant women, this can cause a further difficulty in doing an accurate diagnosis and treatment of haemostatic disorders during pregnancy. In the treatment of critical bleeding in trauma patients have been developed some new insights that may be applied, at least partially, in the management of bleeding patients in obstetrics. In recent years it has been developed an approach called “Damage control resuscitation”, which combines to the surgery a medical treatment aimed at correcting the underlying coagulopathy. This approach is based on three items: minimise use of crystalloids and colloids; optimise fresh frozen plasma (FFP) to red blood cells (RBC) ratio; make an appropriate use of antifibrinolitic agents, fibrinogen and cryoprecipitate.
机译:产后出血(PPH)是孕产妇死亡的最常见原因之一:在全世界范围内,孕产妇死亡占25%。在过去的几十年中,因妊娠并发症而死亡的风险已大大降低,但一些证据表明,尚未将其降至最低。因此,需要进一步改善医疗质量。本文的目的是简要概述PPH的定义,并举例说明当前可用的可能原因和治疗方法。 WHO将PPH定义为阴道分娩后出血> 500 ml,而严重PPH定义为阴道分娩后出血超过1,000 ml,但是已经提出了多种PPH定义,但没有一个令人满意的定义。另一个至关重要的事项是经常基于视觉评估来估计失血量,因此不准确且最小化。但是,在医学文献中,没有针对产科严重出血的具体分类。在怀孕期间,凝血状态会发生一些变化:由于止血参考间隔通常基于未怀孕妇女的样本,因此在准确诊断和治疗怀孕期间的止血疾病时,可能会导致进一步的困难。在创伤患者的严重出血的治疗中,已经开发出一些新的见解,这些见解至少可以部分地应用于产科出血患者的治疗。近年来,已经开发出一种称为“损伤控制复苏”的方法,该方法将旨在纠正潜在凝血病的医学治疗与手术相结合。该方法基于以下三个方面:最小化晶体和胶体的使用;优化新鲜冷冻血浆(FFP)与红细胞(RBC)的比例;适当使用抗纤维蛋白药物,纤维蛋白原和冷沉淀。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号